AFTD 2022 Education Conference: Biomarkers -- The Next Frontier of FTD Research

preview_player
Показать описание
AFTD 2022 Education Conference plenary session: "Biomarkers- The Next Frontier of FTD Research".

Identifying FTD biomarkers is among the most important goals for researchers studying FTD. Establishing biomarkers would allow for more accurate and early diagnosis, better monitoring of FTD progression, and a way to examine treatment effectiveness. This session explains what biomarkers are, explore the current state of FTD biomarker research, and inform you what is on the horizon – and how you can play a role in FTD biomarker development.

Moderator: Debra Niehoff, PhD
Presenters: David Irwin, MD and Tania Gendron, PhD
Рекомендации по теме
Комментарии
Автор

Just wondering is there a cost for the patient to enroll in a research program ?

kimgloria